Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Innoviva, Inc. - Common Stock
(NQ:
INVA
)
22.66
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Innoviva, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Innoviva to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
September 08, 2022
From
Innoviva, Inc.
Via
Business Wire
3 No-Brainer Stocks Under $10 to Buy for September
↗
September 02, 2022
Cash-rich investors have the flexibility to buy no-brainer penny stocks to boost overall returns in a risk-adverse environment.
Via
InvestorPlace
Innoviva Completes Acquisition of La Jolla Pharmaceutical
August 22, 2022
From
Innoviva, Inc.
Via
Business Wire
Innoviva's Return On Capital Employed Overview
↗
August 01, 2022
Pulled from Benzinga Pro data, Innoviva (NASDAQ:INVA) showed a loss in earnings since Q1, totaling $21.37 million. Sales, on the other hand, increased by 20.17% to $108.22 million during Q2.
Via
Benzinga
Innoviva Acquires AstraZeneca-Spin Off At $2.20/Share
↗
May 23, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
↗
July 28, 2022
On Thursday, 108 companies set new 52-week lows.
Via
Benzinga
Innoviva: Q2 Earnings Insights
↗
July 27, 2022
Innoviva (NASDAQ:INVA) reported its Q2 earnings results on Wednesday, July 27, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Innoviva missed estimated earnings...
Via
Benzinga
Innoviva Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress
July 27, 2022
From
Innoviva, Inc.
Via
Business Wire
Overview Of Value Stocks In The Healthcare Sector
↗
July 25, 2022
What is a Value Stock?
Via
Benzinga
The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures
↗
July 14, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2022
↗
July 20, 2022
Upgrades
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
July 13, 2022
Gainers
Via
Benzinga
Theravance Biopharma, Innoviva Gain On Selling TRELEGY ELLIPTA Royalty Interests
↗
July 13, 2022
Via
Benzinga
Innoviva Sells 15% Economic Stake in Theravance Respiratory Company to Royalty Pharma for approximately $282 million plus full ownership of existing equity investments and the potential for $50 million milestone payment
July 13, 2022
From
Innoviva, Inc.
Via
Business Wire
La Jolla Pharmaceutical (LJPC) Stock Skyrockets on Innoviva Acquisition News
↗
July 11, 2022
A headline-grabbing takeover deal could be impactful for the medical community - and today, it's definitely huge news for LJPC stock holders.
Via
InvestorPlace
Innoviva Completes Acquisition of Entasis Therapeutics
July 11, 2022
From
Innoviva, Inc.
Via
Business Wire
The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After Patient Death
↗
July 11, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Innoviva Bolsters Its Infectious Disease, Hospital Portfolio With La Jolla Deal
↗
July 11, 2022
Via
Benzinga
Innoviva to Acquire La Jolla Pharmaceutical Company
July 11, 2022
From
La Jolla Pharmaceutical Company
Via
Business Wire
Innoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Therapeutics Holdings Inc.
July 08, 2022
From
Innoviva, Inc.
Via
Business Wire
5 Value Stocks To Watch In The Healthcare Sector
↗
June 27, 2022
What Defines a Value Stock?
Via
Benzinga
Innoviva to Acquire Entasis Therapeutics
May 23, 2022
From
Innoviva, Inc.
Via
Business Wire
Innoviva Reports First Quarter 2022 Financial Results
April 27, 2022
From
Innoviva, Inc.
Via
Business Wire
Overview Of Value Stocks In The Healthcare Sector
↗
March 28, 2022
What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
Sail Through the Choppy Market With These 4 Low-Beta Stocks
↗
March 05, 2022
Creating a portfolio of low-beta stocks is important since the securities can deliver healthy returns and provide a shield against volatile market conditions.
Via
Talk Markets
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
February 11, 2022
Gainers Dermata Therapeutics (NASDAQ:DRMA) stock rose 29.0% to $1.38 during Friday's pre-market session. The company's market cap stands at $11.4 million. Innoviva...
Via
Benzinga
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
↗
February 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
62 Biggest Movers From Yesterday
↗
February 11, 2022
Gainers American Rebel Holdings, Inc. (NASDAQ: AREB) shares jumped 42.8% to close at $3.07 on Thursday following the company's recent uplisting to the Nasdaq....
Via
Benzinga
Armata Pharma's Largest Shareholder Injects $45M For Its Bacteriophage Development
↗
February 10, 2022
Armata Pharmaceuticals Inc (NYSE: ARMP) has
Via
Benzinga
Innoviva Reports Fourth Quarter 2021 Financial Results
February 09, 2022
From
Innoviva, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
